The global Idiopathic Intracranial Hypertension Treatment market study encloses the projection size of the market both in terms of value (Mn/Bn US$) and volume (x units). With bottom-up and top-down approaches, the report predicts the viewpoint of various domestic vendors in the whole market and offers the market size of the Idiopathic Intracranial Hypertension Treatment market. The analysts of the report have performed in-depth primary and secondary research to analyze the key players and their market share. Continue reading →

Global Pulmonary Arterial Hypertension Market Report Forecast 2028 states overview of epidemiology trends of Pulmonary Arterial Hypertension Industry. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical needs associated with the Pulmonary Arterial Hypertension and contains the targeted patient populations as well as forecast methodology Continue reading →

New data analysis of the ongoing French Cohort of Myocardial Infarction Evaluation (FRENCHIE) registry reveals a decline in hospital admission for acute myocardial infarction following the coronavirus disease 2019 (COVID-19) lockdown. Although the reasons for such findings can only be speculative, the investigators noted that this marked decrease should encourage public health officials to provide appropriate messages that especially target those that are wary of utilizing health services during the pandemic Continue reading →

Multiple cancer treatments, such as regimens that include anthracyclines and molecular targeted therapies, can cause cardiotoxicities. Patients who are at high risk for these dangerous adverse events (AEs) need to be identified and managed appropriately by educating everyone involved in the patients care and establishing collaboration between medical oncologists and cardiologists Continue reading →